Biometrics: Board

Showing posts with label Board. Show all posts

Avery Biomedical Devices, Inc. announces the appointment of Mark E Ginsburg, M.D. to its Board of Directors

COMMACK, N.Y., July 2, 2014 /PRNewswire/ -- It is a great honor for Avery Biomedical Devices, Inc. (ABD) to announce the appointment of the world-renowned Thoracic and Cardiovascular surgeon, Mark E Ginsburg, M.D., to its Board of Directors.

Dr. Ginsburg, with over 34 years of experience, is currently practicing at two facilities: NY Presbyterian Hospital and Good Samaritan Regional Medical Center. Dr. Ginsburg has been implanting the Avery Breathing Pacemaker since the late 1980's and is considered an expert in the implantation of the Avery System. In addition, he has travelled the world to implant the Avery System in those patients who are unable to travel to the United States. He has published numerous scientific papers and books such as Lung Volume Reduction Surgery (LVRS) and Emphysema Treatments. In addition, he was lead investigator on several clinical trials.

Martin Dobelle, CEO, states, "We are humbled to have Dr. Ginsburg join our Board of Directors. His experience and expertise will be invaluable to the future growth of ABD."

Dr. Ginsburg states, "It is a privilege to serve on the Board of Directors of ABD. This company has served the world's need in diaphragm pacing. Exciting new products are under development in this and related arenas as well. I look forward to providing medical and surgical input to the Board."

ABOUT ABD

Avery Biomedical Devices, Inc. is a privately-held company located on Long Island, New York. It manufactures the Avery Breathing Pacemaker System: an implanted diaphragmatic pacemaker which is used to free many quadriplegics, central sleep apnea and diaphragm paralysis patients from mechanical ventilation. Most patients strongly prefer pacing to mechanical ventilation for reasons such as breathing and speech patterns, ease of eating and drinking and improved sense of smell. Since breathing pacemakers costs far less than mechanical ventilation and do not use percutaneous wire that pass through the skin (infection risk), it is the more prudent choice for life support.

The Avery Breathing Pacemaker is the only device of its kind with premarket approval from the USFDA and CE marking privileges under the European Active Implantable Medical Device Directive. Should you know of a patient with quadriplegia, central sleep apnea, diaphragm paralysis or another condition that may benefit from an Avery Breathing Pacemaker, please contact us.

CONTACT:
Martin D. Dobelle, CEO
631-864-1600
www.averybiomedical.com

SOURCE Avery Biomedical Devices, Inc.

RELATED LINKS
http://www.averybiomedical.com/

reade more...

Ten Members of the American Academy of Forensic Sciences Appointed to Forensic Science Standards Board (FSSB)

COLORADO SPRINGS, Colo., June 27, 2014 /PRNewswire/ -- The American Academy of Forensic Sciences (AAFS) announces that the National Institute of Standards and Technology (NIST) and the Department of Justice have appointed 10 of its academic research and forensic science expert members to the Forensic Science Standards Board (FSSB). The Board is an element of the NIST's Organization of Scientific Area Committees (OSAC). These AAFS members are among the first appointments made to the new FSSB that has been established to improve the scientific basis of forensic evidence used in the justice system.

Two AAFS past presidents, Douglas Ubelaker, Ph.D., and Barry Logan, Ph.D., are among the AAFS forensic experts who represent the research community and national forensic science professional organizations.

"AAFS is committed to the advancement of the forensic sciences and its application to the legal system. Our focus is to promote integrity, competency and education, foster research, improve practice and encourage collaboration in the forensic sciences. The Academy shares the common goals of the FSSB and we commend our members for their appointment to this board. We are confident their knowledge, leadership and expertise in their respective disciplines will advance the directives of this important effort, which is intended to strengthen the practice of forensic sciences through improved practices and more consistent quality work protocols," said Daniel A. Martell, Ph.D., AAFS president.

AAFS member appointed are:

Research community representatives:

Sarah Kerrigan, Ph.D., Forensic Science Department chair, Sam Houston State University Douglas Ubelaker, Ph.D., curator, Smithsonian Institution, National Museum of Natural History, Division of Physical AnthropologyNominated by their professional associations:

Andrew Baker, M.D., National Association of Medical Examiners standards committee chair and Hennepin County Medical Examiner, Minn. Laurel Farrell, B.A. Society of Forensic Toxicologists director and past president and American Society of Crime Laboratory Directors/Laboratory Accreditation Board instructor Steven L. Johnson, B.S., International Association for Identification first vice president and Ideal Innovations Inc. certified latent print examiner/facial examiner Barry Logan, Ph.D., American Academy of Forensic Sciences past president and NMS Labs vice president of Forensic Science Initiatives and chief of Forensic Toxicology Jeremy Triplett, M.S., American Society of Crime Laboratory Directors advocacy committee chair and Kentucky State Police Forensic Laboratory supervisor Chairing the OSAC scientific area committees (SAC):

Richard Vorder Bruegge, Ph.D. – SAC IT/Multimedia; Federal Bureau of Investigation, senior photographic technologist Gregory G. Davis, M.D. – SAC Crime Scene/Death Investigation; University of Alabama at Birmingham, professor, division director, and chief coroner/medical examiner George Herrin Jr., Ph.D. – SAC Biology/DNA; Georgia Bureau of Investigation, Division of Forensic Science deputy director The American Academy of Forensic Sciences is a multi-disciplinary professional organization that provides leadership to advance science and its application to the legal system. The objectives of the Academy are to promote integrity, competency, education, foster research, improve practice, and encourage collaboration in the forensic sciences. Organized in 1948, AAFS serves a distinguished and diverse membership of 6,600 forensic science professionals who are the focal point for public information when forensic science issues are addressed in the public domain. AAFS publishes the internationally recognized Journal of Forensic Sciences. For more information visit www.aafs.org

SOURCE American Academy of Forensic Sciences

Secure Identity & Biometrics Association (SIBA) Announces Its Board of Directors, Comprised of the Very Best in Commercial and Strategic Leadership and Identity Expertise

Janice Kephart, SIBA founder and CEO. (PRNewsFoto/Secure Identity & Biometrics Association)jwplayer.key="2kY/GKwZ2uQZmDlQ9VYArfZt2b4+KhHX3+DM4zisgtE=";WASHINGTON, April 9, 2014 /PRNewswire/ -- The Secure Identity & Biometrics Association (SIBA), a non-profit association established in February 2014 to encourage use of solutions that protect and secure identity across private and public platforms, today announces its board members. The new SIBA board represents proven expertise in identity management and biometric solutions, high technology government relations and commercialization, and the defense, intelligence and homeland security communities. "I am so pleased with the diverse and highly relevant experience on the SIBA board," said Janice Kephart, SIBA CEO. "We are already covering new thought leadership ground on the most pressing secure identity and biometric issues, and with a board like this, we will have the ability to reach audiences in business, government and consumer level in a manner unprecedented to date."

Photo - http://photos.prnewswire.com/prnh/20140409/PH01124-a

Logo - http://photos.prnewswire.com/prnh/20140409/PH01124LOGO-b

SIBA board members are:

Jim Annulis, President and CEO, ProQual-I.T., Inc. Ernest Baynard, President, Meridian Hill Strategies Inc. Michael Dougherty, Director of Law Enforcement Solutions, Raytheon Lester Quintana, Senior Vice President, Cellucci Associates Paul Schuepp, President and CEO, Animetrics Matthew Young, Manager, Biometric and Identity Intelligence Solutions, Sotera Defense SolutionsSIBA strategic advisors are:

Reed Stager, President, Five Peaks Group Horace Kephart, former President and CEO, G.O. Carlson Inc. Paul Schuepp and Jim Annulis said this about serving on the SIBA board:

"Animetrics enthusiastically joined SIBA as a founding member. Janice Kephart's timing establishing SIBA, with the current tsunami of activity and demand for the biometric industry and technology providers, was a perfect opportunity for Animetrics to play a significant role in our industry's advocacy and thought leadership. SIBA has created the forum for responsible industry organizations to participate in creation of consensus, economic security, policy and legislative change." - Paul Schuepp

"Being an entrepreneur, I realize that novel concepts keep business and technology moving forward - to challenge the status quo, enabling better ideas to root and flourish. That's not easy to do, but it's necessary. After my first discussion with Janice Kephart, it was evident that she possessed what I consider to be the three necessary characteristics of a change agent: knowledge, influence, and guts. With Janice at SIBA's helm, I think we can introduce new identity management solutions and help people understand how those solutions can improve their lives." - Jim Annulis

Ernest Baynard states: "The global identity management and biometrics community is at a critical crossroads right now with new use cases launching worldwide while decision makers here in the United States continue to make critical decisions regarding the use of new technologies here at home. It is essential that, as a nation, we get this right on both the facts and the policy -- I am confident that SIBA will provide an impactful and insightful voice to this important debate."

Emerging technology and commercialization strategist Dr. Thomas Cellucci, Ph.D., MBA Chairman & CEO of Cellucci Associates, Inc., says of SIBA's potential: "As one who frequently works with the intelligence community, I see great value in the next generation of biometric and identity systems that provide innovation." Cellucci is author of the best seller An Innovative Guide to Public-Private Partnerships. Lester Quintana's view: "Biometrics and identity management are at the core of emerging technologies for all sectors, including global markets. Cellucci Associates believes SIBA is the forum to provide the essential leadership in a dynamic market."

Matthew Young approaches SIBA from the perspective of technology integration and interoperability. "SIBA is well positioned to enable the biometrics industry to integrate into the commercial and government sectors by bringing together SMEs, business leaders, and expertise in legal and policy implications. SIBA has a key responsibility to provide sufficient awareness and information for decision makers and consumers alike, allowing them to determine the appropriate role for biometric and identity technology."

SIBA is a group of vendors and other stakeholders with a common interest in proactive thought leadership, communications and government relations. Its mission is to create awareness and promote the value of secure identity technologies and biometric solutions that effectively protect and secure individuals from identity threats as well as protect and secure facilities, organizations and governments.

For more on SIBA CEO Janice Kephart, see the press release announcing SIBA's establishment here.

http://www.sibassoc.org

Contact:
Janice Kephart
703-581-7721

Read more news from Secure Identity and Biometrics Association.

SOURCE Secure Identity & Biometrics Association

Secure Identity & Biometrics Association (SIBA) Announces Its Board of Directors, Comprised of the Very Best in Commercial and Strategic Leadership and Identity Expertise

Photo - http://photos.prnewswire.com/prnh/20140409/PH01124-a

Logo - http://photos.prnewswire.com/prnh/20140409/PH01124LOGO-b

SIBA board members are:

Reed Stager, President, Five Peaks Group Horace Kephart, former President and CEO, G.O. Carlson Inc. Paul Schuepp and Jim Annulis said this about serving on the SIBA board:

For more on SIBA CEO Janice Kephart, see the press release announcing SIBA's establishment here.

http://www.sibassoc.org

Contact:
Janice Kephart
703-581-7721

Read more news from Secure Identity and Biometrics Association.

SOURCE Secure Identity & Biometrics Association

Avanir Pharmaceuticals Announces Appointment of Mark Corrigan to Board of Directors

Avanir Pharmaceuticals, Inc. (PRNewsFoto/Avanir Pharmaceuticals, Inc.)jwplayer.key="2kY/GKwZ2uQZmDlQ9VYArfZt2b4+KhHX3+DM4zisgtE=";ALISO VIEJO, Calif., March 19, 2014 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the appointment of Dr. Mark Corrigan to the company's board of directors. Dr. Corrigan, a seasoned life sciences executive joins Avanir's board with broad healthcare industry experience.

Dr. Corrigan currently serves as president and chief executive officer of Zalicus Inc. a public biopharmaceutical company, a position he has held since January 2010. He has also served as a director of Zalicus and its progenitor companies since December 2006. Prior to Zalicus, Dr. Corrigan served as executive vice president, research and development at Sepracor, Inc. (now known as Sunovion Pharmaceuticals, Inc.). Prior to joining Sepracor, Dr. Corrigan spent 10 years with Pharmacia & Upjohn, a pharmaceutical company acquired by Pfizer, Inc. in 2003, most recently as group vice president of Global Clinical Research and Experimental Medicine. Prior to joining the pharmaceutical industry, Dr. Corrigan spent five years in academic research at the University of North Carolina Medical School, focusing on psychoneuroendocrinology. Dr. Corrigan has also been a member of the board of directors and audit committee of Cubist Pharmaceuticals, Inc. since June 2008. Dr. Corrigan holds a B.A. and an M.D. from the University of Virginia and subsequently received specialty training in Psychiatry at Cornell and Maine Medical Center.

"It is a pleasure to welcome Mark to the Avanir Board," commented Craig Wheeler, chairman of the board, "Mark brings many years of experience in the healthcare sector combined with a deep knowledge of CNS research and development together with broad experience in guiding the growth of biopharma companies. I look forward to the insights he will bring to our board and to working with him as Avanir pursues its growth initiatives."

About Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit www.avanir.com.

AVANIR® is a trademark or registered trademark of Avanir Pharmaceuticals, Inc. in the United States and other countries.

Avanir Investor & Media Contact
Ian Clements, PhD
ir@avanir.com
+1 (949) 389-6700

Joey Fleury, BrewLife
jfleury@brewlife.com
+1 (415) 946-1090

Logo - http://photos.prnewswire.com/prnh/20130207/LA55901LOGO

SOURCE Avanir Pharmaceuticals, Inc.

Biosyntrx, Inc. Announces New Scientific Advisory Board Members

Steps to the Harvard Library Center of Knowledge. (PRNewsFoto/Biosyntrx, Inc.)jwplayer.key="2kY/GKwZ2uQZmDlQ9VYArfZt2b4+KhHX3+DM4zisgtE=";COLORADO SPRINGS, Colo., Feb. 18, 2014 /PRNewswire/ -- Biosyntrx, Inc., a nutritional biotechnology and healthy lifestyles education company in the ophthalmic sector is proud to announce the addition of three new scientific advisory board members:

(Photo: http://photos.prnewswire.com/prnh/20140218/SF65884)

Lucy Young, MD, is Associate Professor of Ophthalmology at the Massachusetts Eye and Ear Infirmary, Harvard Medical School. She is the director of the Lancaster Course in Ophthalmology and has been on its faculty since 1990. Her publication list includes 95 peer review papers and book chapters. She is on the Best Doctors and U.S. News & World Report Top Doctors lists.

Richard Davis, MD, is a physician, inventor, and successful serial entrepreneur who has authored nearly 400 patents and trademarks worldwide, as well as sold four start-up companies to publicly traded companies. He is currently serving as the Chairman, President, and CEO of OgenX Therapeutics, a privately held mitochondrial medicines company focusing on solutions in Neurodegeneration, Oncology, and Virology in humans and animals.

Vincent de Luise, MD, is Assistant Clinical Professor of Ophthalmology at Yale University School of Medicine and Adjunct Clinical Assistant Professor of Ophthalmology at Weill Cornell Medical College. He serves on the editorial boards of the Cornea Journal and Eye World. As a post-doctoral fellow at Harvard University this past year, he developed a rubric for medical humanities education at both the undergraduate and medical school level.

About Biosyntrx, Inc.: Biosyntrx is a Colorado Springs, Colo.–based Nutritional Biotechnology Company with emphasis on ophthalmic nutrition science, professional crosstalk, and healthy lifestyles education. The primary Biosyntrx Eye Care Professional–recommended products are BioTears, a patented product that addresses the systemic nutrient needs of the dry eye patient, with millions of doses safely used by satisfied repeat customers, Macula Complete, a potent full-spectrum multiple designed for the those concerned about AMD, cataract, diabetic retinopathy, glaucoma, lack of energy, and optimal full-body health, also with millions of doses safely used by satisfied repeat customers. Oculair, a less potent full-body multiple, SightC+ for those who want or need daily or occasional megadoses of mineral-buffered vitamin C, Zeaxanthin-4 for those who want a 4 mg standalone zeaxanthin product, and EpiCor, a clinically proven immune system modulator. ?

For additional information, contact Biosyntrx CEO, Ellen Troyer, at etroyer@biosyntrx.com or office 719-227-7888 or cell 719-660-6676

SOURCE Biosyntrx, Inc.

Markets Poised for Healthy 2014 as Biometrics Makes Strides in Technology Sector - Company Strengthens Board with Industry's Top Leaders

CORAL SPRINGS, Florida, December 18, 2013 /PRNewswire/ --

Tech leaders close out 2013 with beneficial internal moves and acquisitions: NXT-ID, Inc. (OTCQB: NXTD), Symantec Corporation (NASDAQ: SYMC), Avago Technologies Limited (NASDAQ: AVGO), Nuance Communications, Inc. (NASDAQ: NUAN) and Apple Inc. (NASDAQ: AAPL)

NXT-ID, Inc. (OTCQB:NXTD) Headline News: NXT-ID Appoints Two Former MasterCard Executives to Its Newly Formed Advisory Board And Shows First Images of the Biometrically Secure Wallet, The Wocket(TM). NXT-ID, a biometrics company focused on the growing m-commerce market, announces the appointment of two key advisory board members, Mr. Lawrence Flanagan and Mr. Ken Moy. The appointments from the card payment industry align with the company's roll-out and 2014 launch of The Wocket™, a next generation biometrically secure wallet. "We are honored and excited to have two luminaries of the card payment world on our advisory board," said Gino Pereira, CEO of NXT-ID, Inc. "Their experience is invaluable to our future prospects and growth for The Wocket™. We look forward to growing our advisory board over the next few months with equally talented and experienced individuals."

To read the full press release and get more information & specific details regarding Mr. Flanagan and Mr. Moy, please click here: http://finance.yahoo.com/news/nxt-id-appoints-two-former-130155944.html

NXT-ID, Inc. also released the first images of The Wocket(TM) on its corporate website and product website late last week. About The Wocket(TM) - The Wocket(TM) is a next generation designed to replace all the cards in your wallet without draining your cell phone's battery; no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval. http://thewocket.com/

Symantec Corporation (NASDAQ: SYMC) has announced the recipients of the 2013 Symantec Research Labs Graduate Fellowship -- Kai Ren, a Ph.D. candidate in computer science at Carnegie Mellon University, and Christian Rossow, a postdoctoral researcher at Vrije Universiteit Amsterdam in The Netherlands and Ruhr University Bochum in Germany. Symantec Research Labs is the Company's global research division and has developed and helped commercialize numerous next-generation technologies ranging from Symantec's first antispam technology, to the technology used to help protect our nation's critical power-grid infrastructure. The Symantec Research Labs Graduate Fellowship supports graduate students who are conducting innovative research that has real-world value, in the areas of information security and storage systems.

Avago Technologies Limited (NASDAQ: AVGO) and LSI Corporation (NASDAQ: LSI) recently announced that they have entered into a definitive agreement under which Avago will acquire LSI for $11.15 per share in an all-cash transaction valued at $6.6 billion. The acquisition creates a highly diversified semiconductor market leader with approximately $5 billion in annual revenues by adding enterprise storage to Avago's existing wired infrastructure, wireless and industrial businesses. The combined company will be strongly positioned to capitalize on the growing opportunities created by the rapid increases in data center IP and mobile data traffic. "This highly complementary and compelling acquisition positions Avago as a leader in the enterprise storage market and expands our offerings and capabilities in wired infrastructure, particularly system-level expertise," stated Hock Tan, President and Chief Executive Officer of Avago. "This combination will increase the Company's scale and diversify our revenue and customer base. In addition to these powerful strategic benefits, as we integrate LSI onto the Avago platform, we expect to drive LSI's operating margins toward Avago's current levels, creating significant additional value for stockholders."

Nuance Communications, Inc. (NASDAQ: NUAN) has announced that Jetstar has launched a new virtual assistant called "Ask Jess" which is based on Nuance Nina Web, an intelligent virtual assistant that delivers a human-like, conversational customer service experience. Customers simply type to Jess, and Jess provides the answers. Jetstar is the first airline to deploy Nuance Nina Web virtual assistant for customer service. The new Ask Jess virtual assistant draws on Nuance Nina, an intelligent virtual assistant that leverages innovative natural language understanding technology and delivers a conversational interface to web visitors which simulates human conversation. Nuance's Natural Language Understanding (NLU) technology allows applications like Ask Jess to understand a customer's intent through an interactive, text-based chat experience. By understanding what customers want, Ask Jess makes getting information on booking, baggage and seating easier than navigating pages on a Web site. Jetstar's Ask Jess virtual assistant is also fully integrated with the company's existing live chat service, delivering a seamless handover to human support when required.

Apple Inc. (NASDAQ: AAPL) has recently acquired patent number 8,610, 726B2 for its new technology of a built-in project for a computer. Jack Purcher states this invention could create a new category of computers, as it erases the need for a display inside the actual device itself. This computer could project information on virtually any blank surface and would also carry the benefit of having no external wires besides that of a power cord. AAPL closed down .45% on Tuesday afternoon on over 6.7 million shares traded.

FinancialNewsMedia.com is leading provider of third party publishing & news dissemination services. If you would like more information regarding our news coverage solutions, please visit http://www.financialnewsmedia.com for more details. Get an edge on the market with our Premium News Alerts that are FREE for a limited time at http://www.financialnewsmedia.com/. Follow us on Facebook: http://www.facebook.com/financialnewsmedia and Twitter: http://twitter.com/FNMgroup. Sign up for our FREE SMS News alerts delivered directly to your mobile phone by texting the word PRESS to 545454. (SMS alerts are free, however data rates may apply, check your wireless plan for details.)

DISCLAIMER: FN Media Group LLC (FNMG) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNMG is NOT affiliated in any manner with any company mentioned herein. FNMG and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made in this release. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. FNMG was compensated one thousand four hundred dollars for the dissemination of the news released by NXT-ID, Inc. by a non-affiliated third party.

FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.

Contact Information:
Company: FN Media Group, LLC
Contact email: editor@financialnewsmedia.com
U.S. Phone: +1(954)345-0611
URL: http://www.financialnewsmedia.com

SOURCE FN Media Group, LLC

reade more...

Pages

.